Literature DB >> 12628580

Antagonism of aryl hydrocarbon receptor-dependent induction of CYP1A1 and inhibition of IgM expression by di-ortho-substituted polychlorinated biphenyls.

Jaehong Suh1, Jong Soon Kang, Kyu-Hwan Yang, Norbert E Kaminski.   

Abstract

Halogenated aromatic hydrocarbons (HAHs) are ubiquitous environment contaminants that produce many of their toxic effects by binding to the aryl hydrocarbon receptor (AhR). However, several investigations have demonstrated that certain polychlorinated biphenyl (PCB) congeners, principally di-ortho-chlorinated PCB congeners, or mixtures containing multiple di-ortho-chlorinated PCBs, inhibit AhR-mediated responses induced by other toxic HAHs. Most relevant to the present study are past reports demonstrating antagonism by these uniquely acting PCB congeners on AhR agonist-mediated inhibition of humoral immune responses. The mechanism responsible for antagonism of AhR agonists by certain PCBs is presently unknown. The present study evaluated the antagonist activity of several di-ortho-substituted PCB congeners [PCB47 (2,2',4,4'), PCB52 (2,2',5,5'), PCB128 (2,2',3,3',4,4'), and PCB153 (2,2',4,4',5,5')] when present in combination with AhR agonists [TCDD (2,3,7,8,-tetrachlorodibenzo-p-dioxin), PCB126 (3,3',4,4',5), and PCB77 (3,3',4,4')] on CYP1A1 induction and inhibition of lipopolysaccharide (LPS)-induced immunoglobulin production in the CH12.LX B cell line. In contrast to non-ortho-substituted PCB (PCB77), which showed additive effects on CYP1A1 induction in combination with TCDD, all of the di-ortho-substituted PCBs examined produced antagonism. Di-ortho-substituted PCB (PCB52) also antagonized TCDD- or PCB126- mediated inhibition of IgM secretion and immunoglobulin heavy chain mRNA expression in the LPS-activated B cells. In addition, PCB52 inhibited TCDD-induced AhR DNA binding to a dioxin-responsive element. Collectively, these results suggest that the mechanism responsible for antagonism by di-ortho-substituted PCB congeners of AhR agonist-mediated CYP1A1 induction and inhibition of antibody responses in B cells occurs through interference with agonist activation of the cytosolic AhR complex.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12628580     DOI: 10.1016/s0041-008x(02)00040-6

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  17 in total

1.  Developing tools for risk assessment in protected species: Relative potencies inferred from competitive binding of halogenated aromatic hydrocarbons to aryl hydrocarbon receptors from beluga (Delphinapterus leucas) and mouse.

Authors:  Brenda A Jensen; Christopher M Reddy; Robert K Nelson; Mark E Hahn
Journal:  Aquat Toxicol       Date:  2010-07-23       Impact factor: 4.964

2.  Determination of in vitro relative potency (REP) values for mono-ortho polychlorinated biphenyls after purification with active charcoal.

Authors:  A K Peters; P E Leonards; B Zhao; A Bergman; M S Denison; M Van den Berg
Journal:  Toxicol Lett       Date:  2006-05-03       Impact factor: 4.372

3.  The emerging contaminant 3,3'-dichlorobiphenyl (PCB-11) impedes Ahr activation and Cyp1a activity to modify embryotoxicity of Ahr ligands in the zebrafish embryo model (Danio rerio).

Authors:  Monika A Roy; Karilyn E Sant; Olivia L Venezia; Alix B Shipman; Stephen D McCormick; Panithi Saktrakulkla; Keri C Hornbuckle; Alicia R Timme-Laragy
Journal:  Environ Pollut       Date:  2019-08-06       Impact factor: 8.071

4.  Complexities of gene expression patterns in natural populations of an extremophile fish (Poecilia mexicana, Poeciliidae).

Authors:  Courtney N Passow; Anthony P Brown; Lenin Arias-Rodriguez; Muh-Ching Yee; Alexandra Sockell; Manfred Schartl; Wesley C Warren; Carlos Bustamante; Joanna L Kelley; Michael Tobler
Journal:  Mol Ecol       Date:  2017-07-04       Impact factor: 6.185

5.  Persistent aryl hydrocarbon receptor inducers increase with altitude, and estrogen-like disrupters are low in soils of the Alps.

Authors:  Walkiria Levy; Bernhard Henkelmann; Silke Bernhöft; Toine Bovee; Franz Buegger; Gert Jakobi; Manfred Kirchner; Rodolfo Bassan; Norbert Kräuchi; Wolfgang Moche; Ivo Offenthaler; Primoz Simončič; Peter Weiss; Karl-Werner Schramm
Journal:  Environ Sci Pollut Res Int       Date:  2010-06-24       Impact factor: 4.223

6.  Non-additive hepatic gene expression elicited by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 2,2',4,4',5,5'-hexachlorobiphenyl (PCB153) co-treatment in C57BL/6 mice.

Authors:  Anna K Kopec; Michelle L D'Souza; Bryan D Mets; Lyle D Burgoon; Sarah E Reese; Kellie J Archer; Dave Potter; Colleen Tashiro; Bonnie Sharratt; Jack R Harkema; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2011-08-07       Impact factor: 4.219

7.  Aryl hydrocarbon receptor ligands of widely different toxic equivalency factors induce similar histone marks in target gene chromatin.

Authors:  Jerald L Ovesen; Michael Schnekenburger; Alvaro Puga
Journal:  Toxicol Sci       Date:  2011-02-03       Impact factor: 4.849

8.  PCB153-elicited hepatic responses in the immature, ovariectomized C57BL/6 mice: comparative toxicogenomic effects of dioxin and non-dioxin-like ligands.

Authors:  Anna K Kopec; Lyle D Burgoon; Daher Ibrahim-Aibo; Bryan D Mets; Colleen Tashiro; Dave Potter; Bonnie Sharratt; Jack R Harkema; Timothy R Zacharewski
Journal:  Toxicol Appl Pharmacol       Date:  2009-12-18       Impact factor: 4.219

9.  Direct assessment of cumulative aryl hydrocarbon receptor agonist activity in sera from experimentally exposed mice and environmentally exposed humans.

Authors:  Jennifer J Schlezinger; Pamela L Bernard; Amelia Haas; Philippe Grandjean; Pal Weihe; David H Sherr
Journal:  Environ Health Perspect       Date:  2010-05       Impact factor: 9.031

10.  ORAL ADMINISTRATION OF PCBs INDUCES PROINFLAMMATORY AND PROMETASTATIC RESPONSES.

Authors:  Sandor Sipka; Sung-Yong Eum; Kwang Won Son; Shifen Xu; Vasileios G Gavalas; Bernhard Hennig; Michal Toborek
Journal:  Environ Toxicol Pharmacol       Date:  2008-03       Impact factor: 4.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.